Haruhiko Banno

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki et al. · The Lancet Neurology · 2010 · 187 citations

Jasmitt Study, Clinical Injury, Neurological Disorder +10

Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy

Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki et al. · Annals of Neurology · 2009 · 156 citations

CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA

Keisuke Suzuki, Masahisa Katsuno, Haruhiko Banno et al. · Brain · 2007 · 120 citations · Full text

Reversible Disruption of Dynactin 1-Mediated Retrograde Axonal Transport in Polyglutamine-Induced Motor Neuron Degeneration

Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama et al. · Journal of Neuroscience · 2006 · 120 citations · Full text

Disrupted Transforming Growth Factor-β Signaling in Spinal and Bulbar Muscular Atrophy

Masahisa Katsuno, Hiroaki Adachi, Makoto Minamiyama et al. · Journal of Neuroscience · 2010 · 88 citations · Full text